4//SEC Filing
Cystic Fibrosis Foundation 4
Accession 0000950170-24-061622
CIK 0001739174other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:05 PM ET
Size
7.1 KB
Accession
0000950170-24-061622
Insider Transaction Report
Form 4
BiomX Inc.PHGE
Cystic Fibrosis Foundation
10% Owner
Transactions
- Exercise of In-Money
Common Stock, par value $0.0001 per share
2024-05-15$0.00/sh+4,778,265$4,778→ 9,330,580 total - Exercise of In-Money
Warrant to purchase common stock
2024-05-15−4,778,265→ 0 totalExercise: $0.00→ Common stock (4,778,265 underlying)
Footnotes (1)
- [F1]The warrant was exercisable beginning on February 27, 2023, for that number of shares that would not result in the Reporting Person beneficially owning more than 9.99% of the number of shares of common stock then issued and outstanding upon such exercise, and became exercisable in full on May 15, 2024. The warrant does not expire.
Documents
Issuer
BiomX Inc.
CIK 0001739174
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001957515
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:05 PM ET
- Size
- 7.1 KB